Navigation Links
Medivation Reports Year-End 2007 Financial Results and Pipeline Progress
Date:2/19/2008

000,000 shares authorized; 28,837,290 shares issued and

outstanding 288,372

Additional paid-in capital 100,969,362

Deficit accumulated during the development stage (60,199,556)

Total stockholders' equity 41,058,178

Total liabilities and stock and stockholders' equity $45,596,059

MEDIVATION, INC.

(A DEVELOPMENT STAGE COMPANY)

CONSOLIDATED STATEMENTS OF OPERATIONS

Inception

Year ended December 31, (September 4, 2003)

2007 2006 to December 31, 2007

Operating expenses:

General and administrative:

Payroll * $2,819,931 $937,677 $4,647,224

Consulting and other

professional fees * 4,086,689 1,964,819 7,952,822

Other general and

administrative 2,222,262 911,638 4,251,064

Total general and

administrative 9,128,882 3,814,134 16,851,110

Research and development:

Payroll * 5,321,212 1,358,735 7,693,780

Consulting and other

professional fees * 3,869,029 2,306,660 8,316,550

Preclinical and clinical

studies 14,088,491 8,405,044 26,658,806

Other research and

development 1,355,332 261,520 1,981,103

Total research and

development 24,634,064 12,331,959 44,650,239

Total operating expenses 33,762,946 16,146,093 61,501,349

Loss from operations (33,762,946
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Medivation Announces Participation in Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
2. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
3. United Therapeutics Reports Fourth Quarter and Annual 2007 Financial Results
4. Favrille Reports Fourth Quarter and Year End 2007 Financial Results
5. JADO Reports Clinical Proof of Concept With Raft Modulator in Atopic Dermatitis
6. OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) is Feasible in Acute Myocardial Infarction Patients, American Heart Journal Paper Reports
7. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
8. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
9. Escalon(R) Reports Second Quarter Fiscal 2008 Results
10. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
11. Eklin Medical Reports Record Revenues for 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one of ... Nick Maroulis, Pharm.D. to the newly created position of ... this position, Dr. Maroulis will continue to manage the ... our multi-site pharmacies as the company expands. Dr. Maroulis ... time he has served in many different capacities in ...
(Date:12/19/2014)... PLEASANTON, Calif. , Dec. 19, 2014  Roche ... acquisition of Bina Technologies, Inc. (Bina), a privately ... California , USA. Bina provides a big ... next generation sequencing (NGS) data. Bina,s proprietary on-market ... translational and academic researchers to perform fast and ...
(Date:12/19/2014)... , Dec. 19, 2014 Decision Resources Group ... grow at a 12 percent compound annual growth rate ... the aging population and the increasing adoption of dental ... will also spur demand for dental biomaterials ... implant and periodontal treatments. Other key findings ...
(Date:12/19/2014)... Springs, FL (PRWEB) December 18, 2014 ... of the nation’s leading specialty pharmacies, has an ... serve as clinical pharmacy consultants for prescriber offices ... therapy expertise. , “We have a variety ... therapies. For example, those specializing in hepatitis C ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3
... Economic Summit served its purpose by fading away. , ... place between 2000 and 2003 were unsuccessful; on the ... state's growth. But once those general themes were pinpointed, ... them, the Wisconsin Economic Summit needed to give way ...
... - There is nothing that could have been done ... Thursday. But thanks to technology, warning systems for such storms ... F3-grade tornadoes that swept through the south central and western ... of tornadoes here in one day and, undoubtedly, took many ...
... rules, the manufacturer's product going straight to the lap of the ... a roofer or a big business, a single-item purchase is sufficient. ... no costly structures, no bureaucracies and no extra hoards of people ... cheap -- it just takes one call and one quick delivery. ...
Cached Biology Technology:Forum builds on the work of the Wisconsin Economic Summit 2Forum builds on the work of the Wisconsin Economic Summit 3Tornadoes put technology to work 2Tornadoes put technology to work 3Tornadoes put technology to work 4Move over B2B, B2C -- it's M2E time 2Move over B2B, B2C -- it's M2E time 3
(Date:12/11/2014)... 10, 2014  Data Sciences International (DSI), the ... a new series of digital telemetry implants to ... M series, part of the PhysioTel™ Digital platform, ... possible physiologic data when incorporating functional endpoints into ... to toxicology studies has evolved from short ECG ...
(Date:12/10/2014)... DIEGO , Dec. 9, 2014 CIE ... collaboration catalyst that provides the connective tissue that enhances ... enabling them to easily share client-level information; earned a ... to expand to organizations serving seniors aging in community ... Diego" partner on December 11 th 4-6p. ...
(Date:12/5/2014)... , Dec. 4, 2014  Tute Genomics, a ... $2.3 million in Series A1 funding led by UK-based ... also participated in the investment round. "We ... healthcare community adopts next-generation sequencing and seeks new approaches ... Reid Robison , MD MBA, and CEO of ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
... at four major genomics and plant pathology laboratories in ... causative agent of "black rot" disease, which is the ... which represents the largest comparative and functional genomics screen ... is published online today in the journal Genome Research. ...
... the toxins that cause paralytic shellfish poisoning (PSP), but scientists ... protection. PSP toxins interfere with nerve function, and the mutation, ... makes nerves less sensitive to those toxins. , The discovery ... Nature. The authors suggest that it has wide ranging implications ...
... especially when it comes to the vaccine description; be sure ... want to understand what the vaccine is about. , ... The European Vaccine Effort against HIV/AIDS today announced that a ... and NYVAC-HIV-C for the prevention of HIV infection has started ...
Cached Biology News:Scientists identify genes responsible for 'black rot' disease in vegetables 2Mutation in clams protects against paralytic shellfish poisoning but raises human health risk 2'EuroVacc 02' HIV Vaccine Trial Begins 2'EuroVacc 02' HIV Vaccine Trial Begins 3
...
... of systems provide fast and reliable scalable ... proteomics and drug development laboratories. Staccato systems ... Workstation Series, Application Series and Custom Systems ... a remarkably compact system for performing ELISA ...
... low-vibration filter/fan unit provides continuous vertical flow ... 100 (ISO 5) cleanliness standards , ... clean and disinfect , Large, ... to allow insertion of filling machines or ...
... provides a safe, clean environment for ... accord with USP-797 requirements. HEPA filtration ... cleanliness conditions in the work area. ... tilt-up front panel for easy access ...
Biology Products: